Babson’s David Stein: “Succeeding where Theranos failed”

The Sunday Times’ tech correspondent Danny Fortson brings on David Stein, chief executive of Babson Diagnostics, to talk about the importance of blood testing (4:49), why Babson is not Theranos (6:47), trying to compete with that idea (9:26), why they succeeded where Theranos failed (14:34), using a tiny amount of blood (18:23), fighting against the Theranos effect (24:37), being owned by a company they aim to disrupt (26:28), liquid biopsies (28:02), the new age of biological data (32:23), regulatory approval (37:09), and avoiding the spotlight (39:03). Hosted on Acast. See acast.com/privacy for more information.

Om Podcasten

From Silicon Valley to The City, tech journalists Danny Fortson and Katie Prescott bring you the inside track on the new industrial revolution.Co-hosted from San Francisco and London, this weekly podcast delivers the latest news and freshest interviews with the people creating the future.As West Coast Correspondent for The Sunday Times, Danny is on the ground to witness the technological whirlwind that first roared out Silicon Valley. From London, working as The Times' Technology Business Editor, Katie has seen the waves of boom and bust rolling through one of the world's financial capitals. Together they explore this strange new world of high finance and tech giants, explaining how we got here and what is just around the corner. Hosted on Acast. See acast.com/privacy for more information.